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Abstract 
Introduction: Corticobasal syndrome (CBS) has a heterogeneous clinical presentation 
with no specific pathologic substratum. Its accurate diagnosis is a challenge for 
neurologists; in order to establish CBS definitively, postmortem confirmation is required. 
Some clinical and radiological features can help to distinguish it from other 
neurodegenerative conditions, such as Creutzfeldt-Jakob disease (CJD).  
Clinical Case: A 74-year-old woman presented with language impairment, difficulty in 
walking and poor attentiveness that had begun 10 days before. Other symptoms, such as 
asymmetrical extra-pyramidal dysfunction, limb dystonia and ‘alien limb’ phenomena, 
were established over the next 2 months, with rapid progression. Death occurred 3 
months after symptom onset. Laboratory results were normal. Initially, imaging only 
showed restricted diffusion with bilateral parieto-occipital gyri involvement on DWI-MRI, 
with unspecific EEG changes. An autopsy was performed. Brain neuropathology 
confirmed sporadic CJD (sCJD).  
Conclusions: CBS is a heterogeneous clinical syndrome whose differential diagnosis is 
extensive. CJD can occasionally present with clinical characteristics resembling CBS. MRI 
detection of abnormalities in some sequences (FLAIR, DWI), as previously reported, has 
high diagnostic utility for sCJD diagnosis – especially in early stages – when other tests 
can still appear normal. Abnormalities on DWI sequencing may not correlate with 
neuropathological findings, suggesting a functional basis to explain the changes found. 
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Introduction 
The core clinical characteristics of corticobasal syndrome (CBS) include findings 
suggesting cortical dysfunction (apraxia, ‘alien limb’ phenomena, cortical sensory loss, 
myoclonus, mirror movements) and basal ganglia dysfunction (bradykinesia, progressive 
asymmetric rigidity, dystonia, tremor) [1]. 
Subacute CBS-like disorder with rapid progression over a period of weeks has been 
described as a presentation form of sporadic Creutzfeldt-Jakob disease (sCJD) [2]. The 
clinical phenotype and progression of symptoms actually reflect the topographic 
distribution of histopathology more than the specific underlying histology [3]. Diffusion-
weighted MRI images (DWI) can be sensitive enough in early stages of the disease for a 
differential diagnosis [4]. 
We present a CBS case which turned out to be sCJD on postmortem neuropathological 
study. Moreover, we discuss relevant MRI features which may also contribute to the 
diagnosis of sCJD while patients are still alive. 
Clinical Case 
A 74-year-old woman with previous hypertension and hypercholesterolemia was admitted to our 
hospital with a 10-day history of gait disturbance and reduced attentiveness. On initial examination, she 
appeared bradyphrenic with decreased verbal fluency and some comprehension mistakes. She was 
disoriented to time and had prominent dysgraphia. Immediate recall and short-term memory were also 
severely disturbed. She presented ideomotor and ideational apraxia, executive dysfunction as well as 
agraphesthesia and astereognosis with intact primary sensory modalities. Oculomotor function was 
normal except for an increased latency of saccadic eye movements. 
Our patient’s left hand had a mainly dystonic posture, with forced wrist flexion. She had gait apraxia, 
and while speaking her right arm performed occasional aimless movements, wandering out of her view. 
No grasping or myoclonic jerks were noted. Mild cog-wheel rigidity and bradykinesia of the upper and 
lower limbs with right predominance were present. Cranial nerves, motor and cerebellar function and 
deep reflexes were otherwise normal. Over the next 4 weeks she became aphasic, incontinent and 
dysphagic, with severe rigidity and generalized myoclonus. Death occurred 3 months after 
symptomatology onset. 
Laboratory tests, including a complete blood count, blood chemistry, thyroid function test, vasculitis 
markers, HIV and VDRL tests, and vitamin B12 and folate levels, were normal. Cerebrospinal fluid 
biochemistry was normal. Results were positive for 14-3-3 protein, and polymorphism testing at PRNP 
(human prion gene) codon 129 showed homozygosity for methionine (MM1). PRNP gene mutations 
were excluded. MRI performed 2 days after admission revealed bilateral hyperintensity of the cortical 
ribbon of the parieto-occipital cortex on T2 sequences, with gyriform enhancement on DWI (fig. 1). 
Initial electroencephalogram (EEG) showed a severe diffuse slowing. One month later, generalized 
sharp and triphasic waves with a periodic pattern of 1–1.5 Hz were present. 
Autopsy was restricted to the encephalon. Macroscopically, moderate gyral frontal atrophy was 
present. On microscopic sections, the main lesions consisted of spongiform changes characterized by 
multiple round vacuoles within the neuropil in the cerebral cortex (occipital lobe, mainly), cerebellum 
molecular layer and basal ganglia (fig. 2a). Severe neuronal loss and reactive gliosis could also be seen 
along with the spongiform changes and even in places where such changes were minimal or absent. 
Immunohistochemistry for pathological prion protein (PrPsc-monoclonal mouse PrP, clone 3F4; Dako) 
showed extensive cerebral and cerebellar diffuse synaptic-like immunoreactivity (fig. 2b). sCJD was 
diagnosed. 
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Discussion 
CBS encompasses different entities, such as corticobasal degeneration (CBD), 
Alzheimer disease, frontotemporal dementia or progressive supranuclear palsy [3]. CBD 
is a tauopathy whose clinical diagnosis can be difficult [5]. This limitation highlights the 
relevancy of other diagnostic procedures, such as MRI. On MRI, CBD patients may 
present asymmetric frontoparietal and midcallosal atrophy [6, 7]. Additionally, on T2-
weighted and fluid-attenuated inversion recovery (FLAIR) images, they may also show 
putaminal hypointensity and subtle subcortical periventricular hyperintensity [8, 9]. On 
DWI, extensive hyperintensity in the frontoparietal white matter, especially on the 
predominant side of cortical atrophy, has been described [8]. These features are especially 
evident in the early course of CBD [8]. 
sCJD is the most frequent human prion disease. Its diagnostic criteria include clinical 
characteristics and auxiliary investigations, such as EEG results and surrogate biomarkers 
in the cerebrospinal fluid [10]. However, definitive diagnosis is neuropathological [10], 
either by immunohistochemical evidence of pathogenic prion deposits, or by the typical 
migration profile of prion protein on Western blot. 
In recent years, a series of publications has demonstrated a potentially important role 
for MRI, not only in diagnosing sCJD in living patients, but also in identifying its distinct 
molecular subtypes [10, 11]. The highest diagnostic accuracy is obtained by finding high 
signal abnormalities either in at least 2 cerebral cortical regions (temporal, parietal or 
occipital) or in the basal ganglia (both caudate nucleus and putamen) in FLAIR or DWI 
sequences [10–12]. Accordingly, an amendment to the classic criteria for sCJD has been 
proposed to include these MRI abnormalities [10]. While in sCJD the characteristic DWI 
appearance seems to be restricted to diffusion in the cortical ribbon and basal ganglia 
structures, in CBS hyperintensity in frontoparietal white matter, mainly on the 
predominant side of cortical atrophy, may be seen [10]. 
The pathophysiological basis for restricted diffusion in cases of spongiform 
encephalopathy remains unknown [13]. While some hypotheses propose that it is 
secondary to vacuoles or prion protein deposition on β-pleated sheet conformation [13], 
others interpret it as active gliosis [14]. 
Initially, our patient displayed symptoms of parietal dysfunction and acute dementia. 
Some typical clinical features of sCJD, such as pyramidal signs, ataxia, visual signs or 
myoclonus, were absent at this stage. CBS with symptoms and signs of higher cortical 
dysfunction has been reported previously as a presentation form of sCJD [2, 15, 16]. 
Parietal lobe dysfunction without dementia was present with basal ganglia signs in one 
case, as in our patient [16]. Also similar to our patient, nonsense hand movements 
without ‘foreign’ hand sensation have been described using the term ‘wayward hand’ [16]; 
such movements are related to a contralateral lesion of the supplementary motor area 
[17]. Disease duration in the other cases was longer (6 and 8 months, and 4 years, 
respectively) [13, 16, 18]. Nevertheless, protein 14-3-3 was negative in 2 of those cases, 
likely reflecting a focal neuronal destruction [13, 16]. MRI on long TR sequences (FLAIR, 
T2) in 1 of the cases [16], as in ours with cortical ribbon hyperintensity, was helpful in 
diagnosis. 
The DWI signal with bilateral parieto-occipital hyperintensities was in fact a useful and 
sensitive tool to distinguish between CJD and CBS, as reported before [4, 15]. 
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Abnormalities seen on DWI usually correlate with clinical exam findings, but not 
necessarily closely with neuropathological findings, especially in early disease stages [4]. 
This case highlighted the classic neuropathological features of sCJD [19]. The severity 
of these abnormalities is usually related to disease duration, and this fact may have 
accounted for the paucity of spongiform change found in our patient. In addition to the 
conventional histopathological study, detection of extensive accumulation of pathological 
prion protein (PrPsc) by immunohistochemistry confirmed the diagnosis [20]. The 
atypical clinical presentation and the utility of DWI or FLAIR signal changes in MRI as 
part of the sCJD diagnostic process are supported by this case. 
 
 
 
 
 
 
Fig. 1. DWI-MRI showing gyriform enhancement (white arrow). 
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Fig. 2. a Occipital lobe – moderate cortical spongiform change and proliferation of reactive astrocytes. 
HE. ×40 (original magnification). b Cerebellum – cortical deposits of pathogenic PrP in a diffuse 
synaptic pattern. Monoclonal antibody 3F4. ×40 (original magnification). 
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